{
    "medicine_id": "8a765a3041ba37b039b186169af30e98e66ab65f",
    "platform_id": "DB08898",
    "metadata": {
        "name": "Voraxaze 1000 USP U 1 Injection powder for solution",
        "composition": "1000 USP U 1 Glucarpidase",
        "clinical_particulars": {
            "therapeutic_indications": "Used in patients on methotrexate treatment who have kidney dysfunction and are experiencing an abnormally high plasma concentration of methotrexate 1 micromole per liter",
            "contraindications": {
                "disease": "Most common adverse reactions include hypotension flushing nausea vomiting headache and paresthesia",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Glucarpidase acts as an antidote to toxic methotrexate levels by elminating methotrexate by a non kidney route",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00116",
                        "description": "The serum concentration of the active metabolites of Tetrahydrofolic acid can be reduced when Tetrahydrofolic acid is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "The serum concentration of the active metabolites of Folic acid can be reduced when Folic acid is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB00650",
                        "description": "The serum concentration of the active metabolites of Leucovorin can be reduced when Leucovorin is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB02031",
                        "description": "The serum concentration of the active metabolites of 6S 5 6 7 8 tetrahydrofolic acid can be reduced when 6S 5 6 7 8 tetrahydrofolic acid is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB02067",
                        "description": "The serum concentration of the active metabolites of Triglu 5 formyl tetrahydrofolate can be reduced when Triglu 5 formyl tetrahydrofolate is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB03256",
                        "description": "The serum concentration of the active metabolites of 6R Folinic acid can be reduced when 6R Folinic acid is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB04789",
                        "description": "The serum concentration of the active metabolites of 5 methyltetrahydrofolic acid can be reduced when 5 methyltetrahydrofolic acid is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB11256",
                        "description": "The serum concentration of the active metabolites of Levomefolic acid can be reduced when Levomefolic acid is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB11596",
                        "description": "The serum concentration of the active metabolites of Levoleucovorin can be reduced when Levoleucovorin is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The metabolism of Raltitrexed can be increased when combined with Glucarpidase"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The metabolism of Methotrexate can be increased when combined with Glucarpidase"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The metabolism of Pemetrexed can be increased when combined with Glucarpidase"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The metabolism of Pralatrexate can be increased when combined with Glucarpidase"
                    },
                    {
                        "drugbank-id": "DB12769",
                        "description": "The metabolism of Lometrexol can be increased when combined with Glucarpidase"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}